Skip to content

Association of Continuous Renal Replacement Therapy With Mortality and Length of Stay in Critically Burned Patients

The Relationship Between Continuous Renal Replacement Therapy, Mortality, and Hospital Length of Stay in Critically Ill Burn Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07195565
Acronym
CRRT-BURN
Enrollment
238
Registered
2025-09-26
Start date
2021-01-01
Completion date
2024-01-01
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Critical Illness, Severe Burns

Keywords

Continuous Renal Replacement Therapy, RIFLE Criteria, Mortality, Hospital Length of Stay, Mechanical Ventilation, İnotropic Support

Brief summary

This retrospective observational study aims to investigate the clinical outcomes of critically ill burn patients who underwent continuous renal replacement therapy (CRRT). Primary endpoints include the evaluation of RIFLE criteria, timing of CRRT initiation, and overall survival. Secondary endpoints consist of comorbidity status, requirement for mechanical ventilation, inotropic support, and hospital length of stay among non-survivors.

Detailed description

Severe burn injury is frequently complicated by acute kidney injury (AKI), which is associated with high morbidity and mortality in intensive care settings. Continuous renal replacement therapy (CRRT) is often required in this patient population; however, the prognostic factors influencing survival remain incompletely defined. In this retrospective study, we analyzed critically ill burn patients who required CRRT. The primary outcomes were the RIFLE classification at the time of CRRT initiation, the timing of therapy initiation, and patient survival. The secondary outcomes included the presence of comorbidities, the need for mechanical ventilation, inotropic support, and length of hospital stay in non-survivors. By systematically evaluating these clinical parameters, the study aims to clarify the prognostic impact of CRRT in burn patients and to contribute evidence for optimizing the management of acute kidney injury in this critically ill population.

Interventions

None listed

Sponsors

Pinar Timur Tasci
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years and older * Admitted to and treated in the Burn Intensive Care Unit

Exclusion criteria

* Patients with an ICU stay of less than 24 hours * Patients younger than 18 years * Patients with known chronic kidney disease or history of kidney transplantation * Patients admitted with toxic epidermal necrolysis (TEN) * Patients with estimated glomerular filtration rate (eGFR) ≤ 15 mL/min/1.73m² at admission

Design outcomes

Primary

MeasureTime frameDescription
RIFLE criteria classification at CRRT initiationBaseline( Day0, at CRRT initiation)Patients receiving CRRT will be classified according to the RIFLE criteria (Risk, Injury, Failure, Loss, End-stage kidney disease) at the time of CRRT initiation. The distribution across categories will be analyzed.
Timing of CRRT initiationBaseline( Day0, at CRRT initiation, recorded from patient medical records)Date and time of initiation of continuous renal replacement therapy (CRRT), obtained from patient medical records.
Survival status of patientsAt hospital discharge ( end of hospitalization)Survival versus non-survival status at the end of hospitalization.

Secondary

MeasureTime frameDescription
Presence of comorbidities in non-survivorsBaseline( Day0, at hospital admission)Documentation of chronic comorbidities (e.g., diabetes, hypertension, cardiovascular disease) in patients who died after CRRT.
Hospital length of stay in non-survivorsFrom hospital admission through study completion( up to discharge or death)Total length of hospitalization measured in days for patients who did not survive after CRRT.
Requirement for mechanical ventilation in non-survivorsThrough ICU stay, up to hospital discharge (or death)Need for invasive mechanical ventilation among non-survivors receiving CRRT.
Requirement for inotropic support in non-survivorsThrough ICU stay, up to hospital discharge or deathRequirement for vasopressor or inotropic agents among non-survivors receiving CRRT.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026